Canada Pension Plan Investment Board’s Aldeyra Therapeutics ALDX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$80.1K	Buy	47,400 +11,900	+34%	+$52.1K	﹤0.01%	1659
2025 Q4	$184K	Buy	+35,500	New	+$182K	﹤0.01%	1689
2019 Q2	–	Sell	-275	Closed	-$2K	–	1238
2019 Q1	$2K	Buy	+275	New	+$2.34K	﹤0.01%	1487

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Canada Pension Plan Investment Board's ALDX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Aldeyra Therapeutics (ALDX) stake by 34% in Q1 2026, buying an estimated $52.1K and bringing the position to 47,400 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Canada Pension Plan Investment Board first reported a position in ALDX in Q1 2019 and has held it in 3 quarters since. The position peaked at $184K in Q4 2025. 127 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

Canada Pension Plan Investment Board held 47,400 shares of Aldeyra Therapeutics worth $80.1K as of Q1 2026.
Canada Pension Plan Investment Board bought 11,900 Aldeyra Therapeutics shares in Q1 2026, an estimated $52.1K.
Aldeyra Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1659 holding.
Canada Pension Plan Investment Board first reported a position in Aldeyra Therapeutics in Q1 2019 and has held it in 3 quarters since.
Canada Pension Plan Investment Board's Aldeyra Therapeutics position peaked at $184K in Q4 2025.
127 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.